Add like
Add dislike
Add to saved papers

A review on Wickerhamomyces anomalus yeast: a promising eco-friendly approach to biological controlof malaria.

Malaria is a deadly parasitic disease transmitted by female Anopheles mosquitoes. One of the most extensive malaria control measures proposed by the World Health Organization (WHO), which has received better attention in recent years, is the biological control of Anopheles mosquitoes. In this concept, Wickerhamomyces anomalus yeast has received more attention from researchers in this field. In the present review, we have investigated the anti-malaria effect of Wickerhamomyces anomalous. In the present review, we searched PubMed, ProQuest, Scopus, Embase, Google Scholar, Science Direct, and Wiley databases for relevant articles. Keywords used in the inquiries were biological control, yeast, Wickerhamomyces anomalus, malaria, Anopheles mosquito, and Plasmodium. Wickerhamomyces anomalus has a wide range of anti-microbial activity. By producing killer toxins (KT), this yeast can kill microorganisms, so it has called killer yeast. This was investigated and proven using monoclonal antibody, western blot analysis and immunofluorescence (IFA) technique. It has also been used in various studies regarding the biological control of malaria by killing Anopheles mosquito larvae. Considering the proven lethal effect of toxins produced by Wickerhamomyces anomalus, the results could be a big step forward towards ending the life cycle of malaria parasites in the body of vector mosquitos.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app